Trial Profile
Study of PSK combination therapy aiming adverse events reduction by TS-1 in advanced gastric cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Polysaccharide K (Primary) ; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Adverse reactions
- 05 Mar 2013 New trial record